Home > Publications Database > Callosal tissue loss in multiple system atrophy--a one-year follow-up study. > print |
001 | 136134 | ||
005 | 20250325111549.0 | ||
024 | 7 | _ | |a 10.1002/mds.23318 |2 doi |
024 | 7 | _ | |a pmid:20623690 |2 pmid |
024 | 7 | _ | |a pmc:PMC2989455 |2 pmc |
024 | 7 | _ | |a 0885-3185 |2 ISSN |
024 | 7 | _ | |a 1531-8257 |2 ISSN |
024 | 7 | _ | |a altmetric:542759 |2 altmetric |
037 | _ | _ | |a DZNE-2020-02456 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Minnerop, Martina |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
245 | _ | _ | |a Callosal tissue loss in multiple system atrophy--a one-year follow-up study. |
260 | _ | _ | |a New York, NY |c 2010 |b Wiley |
264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2010-07-08 |
264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2010-11-15 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1742897712_24043 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Multiple system atrophy (MSA) is a neurodegenerative disease not only affecting the basal ganglia, brainstem, cerebellum, and intermediolateral cell columns of the spinal cord but also the cerebral cortex. Clinically, cerebellar (MSA-C) and parkinsonian variants of MSA (MSA-P) are distinguished. We investigated 14 MSA patients (10 MSA-C, 4 MSA-P, men: 7, women: 7; age: 61.1 ± 3.3 years) and 14 matched controls (men: 7, women: 7; age: 58.6 ± 5.1 years) with voxel-based morphometry (VBM) to analyze gray and white matter differences both at baseline and at follow-up, 1 year later. Baseline comparisons between patients and controls confirmed significantly less gray matter in MSA in the cerebellum and cerebral cortex, and significantly less white matter in the cerebellar peduncles and brainstem. Comparisons of tissue-loss profiles (i.e., baseline versus follow-up) between patients and controls, revealed white matter reduction in MSA along the middle cerebellar peduncles, reflecting degeneration of the ponto-cerebellar tract as a particularly prominent and progressive morphological alteration in MSA. Comparisons between baseline and follow-up, separately performed in patients and controls, revealed additional white matter reduction in MSA along the corpus callosum at follow-up. This was replicated through additional shape-based analyses indicating a reduced callosal thickness in the anterior and posterior midbody, extending posteriorly into the isthmus. Callosal atrophy may possibly reflect a disease-specific pattern of neurodegeneration and cortical atrophy, fitting well with the predominant impairment of motor functions in the MSA patients. |
536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
542 | _ | _ | |i 2015-09-01 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
650 | _ | 2 | |a Aged |2 MeSH |
650 | _ | 2 | |a Atrophy: pathology |2 MeSH |
650 | _ | 2 | |a Brain Stem: pathology |2 MeSH |
650 | _ | 2 | |a Cerebellum: pathology |2 MeSH |
650 | _ | 2 | |a Corpus Callosum: pathology |2 MeSH |
650 | _ | 2 | |a Female |2 MeSH |
650 | _ | 2 | |a Follow-Up Studies |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Image Processing, Computer-Assisted |2 MeSH |
650 | _ | 2 | |a Magnetic Resonance Imaging |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Middle Aged |2 MeSH |
650 | _ | 2 | |a Multiple System Atrophy: pathology |2 MeSH |
700 | 1 | _ | |a Lüders, Eileen |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Specht, Karsten |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Ruhlmann, Jürgen |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Schimke, Nicole |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Thompson, Paul M |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Chou, Yi Y |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Toga, Arthur W |0 P:(DE-HGF)0 |b 7 |
700 | 1 | _ | |a Abele, Michael |0 P:(DE-HGF)0 |b 8 |
700 | 1 | _ | |a Wüllner, Ullrich |0 P:(DE-HGF)0 |b 9 |
700 | 1 | _ | |a Klockgether, Thomas |0 P:(DE-2719)2810314 |b 10 |e Last author |
773 | 1 | 8 | |a 10.1002/mds.23318 |b : Wiley, 2010-07-08 |n 15 |p 2613-2620 |3 journal-article |2 Crossref |t Movement Disorders |v 25 |y 2010 |x 0885-3185 |
773 | _ | _ | |a 10.1002/mds.23318 |g Vol. 25, no. 15, p. 2613 - 2620 |0 PERI:(DE-600)2041249-6 |n 15 |q 25:15<2613 - 2620 |p 2613-2620 |t Movement disorders |v 25 |y 2010 |x 0885-3185 |
856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989455 |
856 | 4 | _ | |u https://pub.dzne.de/record/136134/files/DZNE-2020-02456_Restricted.pdf |
856 | 4 | _ | |u https://pub.dzne.de/record/136134/files/DZNE-2020-02456_Restricted.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:pub.dzne.de:136134 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2810314 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
914 | 1 | _ | |y 2010 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MOVEMENT DISORD : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b MOVEMENT DISORD : 2017 |
920 | 1 | _ | |0 I:(DE-2719)999999 |k Pre 2020 |l DZNE before 2020 |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1011101 |k Patient Studies (Bonn) |l Patient Studies (Bonn) |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)999999 |
980 | _ | _ | |a I:(DE-2719)1011101 |
980 | _ | _ | |a UNRESTRICTED |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.32.1.28 |2 Crossref |o 10.1136/jnnp.32.1.28 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.52.Suppl.78 |2 Crossref |o 10.1136/jnnp.52.Suppl.78 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/117.2.235 |2 Crossref |o 10.1093/brain/117.2.235 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.57.9.1047 |2 Crossref |o 10.1136/jnnp.57.9.1047 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/117.4.835 |2 Crossref |o 10.1093/brain/117.4.835 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/121.4.589 |2 Crossref |o 10.1093/brain/121.4.589 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awf117 |2 Crossref |o 10.1093/brain/awf117 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2003.08.028 |2 Crossref |o 10.1016/j.neuroimage.2003.08.028 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.21032 |2 Crossref |o 10.1002/mds.21032 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2007.04.028 |2 Crossref |o 10.1016/j.neuroimage.2007.04.028 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2005.12.006 |2 Crossref |o 10.1016/j.neuroimage.2005.12.006 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-005-0708-0 |2 Crossref |o 10.1007/s00415-005-0708-0 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2004.11.022 |2 Crossref |o 10.1016/j.neuroimage.2004.11.022 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-002-0734-0 |2 Crossref |o 10.1007/s00415-002-0734-0 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awl021 |2 Crossref |o 10.1093/brain/awl021 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-006-0325-6 |2 Crossref |o 10.1007/s00415-006-0325-6 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0022-510X(98)00304-9 |2 Crossref |o 10.1016/S0022-510X(98)00304-9 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1006/nimg.2001.0786 |2 Crossref |o 10.1006/nimg.2001.0786 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2005.02.018 |2 Crossref |o 10.1016/j.neuroimage.2005.02.018 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/cercor/bhi112 |2 Crossref |o 10.1093/cercor/bhi112 |
999 | C | 5 | |y 1995 |2 Crossref |o Benjamini 1995 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/cercor/9.7.712 |2 Crossref |o 10.1093/cercor/9.7.712 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.3732-07.2008 |2 Crossref |o 10.1523/JNEUROSCI.3732-07.2008 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.2006.104075 |2 Crossref |o 10.1136/jnnp.2006.104075 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2007.05.028 |2 Crossref |o 10.1016/j.neuroimage.2007.05.028 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1552-6569.2008.00273.x |2 Crossref |o 10.1111/j.1552-6569.2008.00273.x |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1552-6569.2008.00262.x |2 Crossref |o 10.1111/j.1552-6569.2008.00262.x |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2009.05.013 |2 Crossref |o 10.1016/j.neuroimage.2009.05.013 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuroimage.2006.05.044 |2 Crossref |o 10.1016/j.neuroimage.2006.05.044 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/0006-8993(92)90178-C |2 Crossref |o 10.1016/0006-8993(92)90178-C |
999 | C | 5 | |y 1992 |2 Crossref |o Costa 1992 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-002-0764-7 |2 Crossref |o 10.1007/s00415-002-0764-7 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.10502 |2 Crossref |o 10.1002/mds.10502 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.20656 |2 Crossref |o 10.1002/mds.20656 |
999 | C | 5 | |y 1986 |2 Crossref |t Cerebral cortex |o Innocenti Cerebral cortex 1986 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1159/000088526 |2 Crossref |o 10.1159/000088526 |
999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jnnp.69.5.623 |2 Crossref |o 10.1136/jnnp.69.5.623 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|